Should I buy Viavi Solutions (VIAV) stock or is it too late?
⭐ The most reliable of them, either direction: Stifel — 70% of its targets hit on this sector (205 calls tested). It aims for $65 (+69 %), call made on August 7, 2026, maturing on August 7, 2027 (21 d ago).
Firm-by-firm track record on Viavi Solutions
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Needham | 86 % | +103.8 % | 7 | $60 +56% |
| Rosenblatt | 53 % | +92.4 % | 15 | $70 +82% |
| Stifel | 100 % | +40.7 % | 7 | $65 +69% |
| B. Riley Securities | 86 % | +22.3 % | 7 | $60 +56% |
| Susquehanna | 20 % | -14.1 % | 5 | $66 +72% |
✅ Reasons to believe
- 83% of analysts rate it a buy (Buy consensus, 6 ratings) — a sign of market conviction.
- Median price target $63, i.e. +63% from the current price ($38).
⚠️ Reasons to hesitate
- Even the most reliable firm on VIAV, Argus Research (100% hit rate, 2 scored calls), only targets $23 (call made on November 5, 2025, maturing on November 5, 2026) (-40%) in its most recent call. The stock may already have run past its target.
- The consensus is not unanimous: of 6 ratings, 1 is neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
The analyst consensus on VIAV
Median target $63 (+63%) · 6 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Viavi Solutions now?
We won't decide for you. The facts: 83% of analysts rate it a buy, median target $63 (+63%), and Argus Research (most reliable on VIAV, 100%) targets $23. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Viavi Solutions?
Not according to analysts: the median target ($63) is still +63% above the current price ($38) (most reliable on VIAV: Argus Research, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Viavi Solutions still worth investing in?
It depends on the gap between the price ($38) and its estimated value: analysts target $63 on median (+63%), with 83% buys (most reliable on VIAV: Argus Research, 100%). Cross-check with their real reliability on VIAV and the cautions above. Information, not advice.
What's the main risk in buying VIAV?
Even the most reliable firm on VIAV, Argus Research (100% hit rate, 2 scored calls), only targets $23 (call made on November 5, 2025, maturing on November 5, 2026) (-40%) in its most recent call. The stock may already have run past its target.
→ Go deeper: the full Viavi Solutions profile (consensus, analyst reliability, price target, performance).